Matches in SemOpenAlex for { <https://semopenalex.org/work/W2408458051> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W2408458051 endingPage "48" @default.
- W2408458051 startingPage "335" @default.
- W2408458051 abstract "As decided in the protocol, the AICLA study ended when all the 604 patients had completed a follow up of three years. Adhesion to the protocol and drug compliance were excellent. Side effects, particularly peptic ulcers and bleedings of various origins were more frequent in the 2 treatment groups containing aspirin. The number of fatal and non fatal cerebral infarction was 31 in the P group, 17 in the ASA group, and 18 in the ASA + D group. Taking into account the duration of follow up for each patient, these figures correspond to cummulate rates of 18 p. 100 in the P group and 10.5 p. 100 in the 2 others. Analysis with the Mantel Method showed: 1 - a difference at the 6 p. 100 level between the 3 groups and between P an AD; 2 - A difference at the 5 p. 100 level between P and A; 3 - No difference between A and AD; 4 - A difference at the 2 p. 100 level between the P group and the two treated groups taken together. Among other diseases occurring during the trial, the only significant difference concerned myocardial infarction, less frequent in the 2 treated groups (p less than 0.05). Subgroup analysis failed to show a significant sex difference in the efficacy of aspirin. It is concluded that, in patients such as those defined in the protocol, Aspirin (1 g) has a significant beneficial effect in the secondary prevention of atherothrombotic cerebral infarction." @default.
- W2408458051 created "2016-06-24" @default.
- W2408458051 creator A5001219856 @default.
- W2408458051 creator A5007962268 @default.
- W2408458051 creator A5010197863 @default.
- W2408458051 creator A5018257231 @default.
- W2408458051 creator A5032291538 @default.
- W2408458051 creator A5038732763 @default.
- W2408458051 creator A5050529049 @default.
- W2408458051 date "1983-01-01" @default.
- W2408458051 modified "2023-09-23" @default.
- W2408458051 title "[The A.I.C.L.A. controlled cooperative trial. Secondary prevention of cerebral ischemic accidents due to atherosclerosis by aspirin and dipyridamole. 3: Results]." @default.
- W2408458051 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6351216" @default.
- W2408458051 hasPublicationYear "1983" @default.
- W2408458051 type Work @default.
- W2408458051 sameAs 2408458051 @default.
- W2408458051 citedByCount "2" @default.
- W2408458051 crossrefType "journal-article" @default.
- W2408458051 hasAuthorship W2408458051A5001219856 @default.
- W2408458051 hasAuthorship W2408458051A5007962268 @default.
- W2408458051 hasAuthorship W2408458051A5010197863 @default.
- W2408458051 hasAuthorship W2408458051A5018257231 @default.
- W2408458051 hasAuthorship W2408458051A5032291538 @default.
- W2408458051 hasAuthorship W2408458051A5038732763 @default.
- W2408458051 hasAuthorship W2408458051A5050529049 @default.
- W2408458051 hasConcept C126322002 @default.
- W2408458051 hasConcept C168563851 @default.
- W2408458051 hasConcept C2776890861 @default.
- W2408458051 hasConcept C2777628954 @default.
- W2408458051 hasConcept C2777798775 @default.
- W2408458051 hasConcept C2779450755 @default.
- W2408458051 hasConcept C3018023364 @default.
- W2408458051 hasConcept C42219234 @default.
- W2408458051 hasConcept C500558357 @default.
- W2408458051 hasConcept C541997718 @default.
- W2408458051 hasConcept C71924100 @default.
- W2408458051 hasConceptScore W2408458051C126322002 @default.
- W2408458051 hasConceptScore W2408458051C168563851 @default.
- W2408458051 hasConceptScore W2408458051C2776890861 @default.
- W2408458051 hasConceptScore W2408458051C2777628954 @default.
- W2408458051 hasConceptScore W2408458051C2777798775 @default.
- W2408458051 hasConceptScore W2408458051C2779450755 @default.
- W2408458051 hasConceptScore W2408458051C3018023364 @default.
- W2408458051 hasConceptScore W2408458051C42219234 @default.
- W2408458051 hasConceptScore W2408458051C500558357 @default.
- W2408458051 hasConceptScore W2408458051C541997718 @default.
- W2408458051 hasConceptScore W2408458051C71924100 @default.
- W2408458051 hasIssue "5" @default.
- W2408458051 hasLocation W24084580511 @default.
- W2408458051 hasOpenAccess W2408458051 @default.
- W2408458051 hasPrimaryLocation W24084580511 @default.
- W2408458051 hasRelatedWork W2019133497 @default.
- W2408458051 hasRelatedWork W2100584536 @default.
- W2408458051 hasRelatedWork W2280777597 @default.
- W2408458051 hasRelatedWork W2325875262 @default.
- W2408458051 hasRelatedWork W2355819178 @default.
- W2408458051 hasRelatedWork W2384490753 @default.
- W2408458051 hasRelatedWork W2408458051 @default.
- W2408458051 hasRelatedWork W2416441689 @default.
- W2408458051 hasRelatedWork W2425224459 @default.
- W2408458051 hasRelatedWork W4290396191 @default.
- W2408458051 hasVolume "139" @default.
- W2408458051 isParatext "false" @default.
- W2408458051 isRetracted "false" @default.
- W2408458051 magId "2408458051" @default.
- W2408458051 workType "article" @default.